# Algorithmiq

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/algorithmiq

- Industry: Biotechnology
- Headquarters: Milan, Italy
- Website: www.algorithmiq.fi/
- Total disclosed funding: $19M
- Latest round: Series A (Jun 27, 2023)
- Investors on record: 6

## About

Based in Turku, Finland, and founded in 2020 by its CEO, Sabrina Maniscalco, CSO, Guillermo García-Pérez, CTO, Matteo Rossi, Lead Researcher, Boris Sokolov, and Jussi Westergren, Algorithmiq, Inc., operates as a developer of scalable quantum computers for solving currently inaccessible problems in life sciences. In May 2026, Algorithmiq, Inc raised EUR 18 million in venture funding co-led by investors United Ventures and Cassa Depositi e Prestiti, with participation from investor Inventure.

The company offers quantum algorithms made using quantum information, complex systems, and computational physics to solve life-science problems.

The company’s quantum chemistry platform, Aurora, can solve the common bottleneck in computer-aided drug design based on IP-protected variational algorithms.

The company plans to use May 2026 funding to scale its commercial operations, expand its team, and accelerate development and industrialisation of quantum software to enable real-world applications across scientific and industrial domains.

## Funding rounds

- Series A, Jun 27, 2023, $15M — Tesi, Inventure, Presidio Ventures, Thames Trust
- Seed, Jan 30, 2022, $4M — Tiger Global Management, K5 Global

## Investors

- Tiger Global Management (https://capitalatlas.ai/funds/tiger-global-management) — Seed
- K5 Global (https://capitalatlas.ai/funds/k5-global) — Seed
- Tesi (https://capitalatlas.ai/funds/tesi) — Series A
- Inventure (https://capitalatlas.ai/funds/inventure) — Series A
- Presidio Ventures (https://capitalatlas.ai/funds/presidio-ventures) — Series A
- Thames Trust — Series A